<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35291547</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2168-8184</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>14</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cureus</Title>
          <ISOAbbreviation>Cureus</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inpatient Management of Encephalopathy.</ArticleTitle>
        <Pagination>
          <StartPage>e22102</StartPage>
          <MedlinePgn>e22102</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e22102</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.22102</ELocationID>
        <Abstract>
          <AbstractText>Unexplained encephalopathy is a common occurrence in tertiary care centers and neurologic disorders should be considered after ruling out the infectious, toxic and metabolic etiologies. Neuroimaging combined with a thorough history and examination is often helpful in ruling out stroke and fulminant demyelinating encephalopathies. Autoimmune encephalopathy should be suspected in any patient with unexplained acute or subacute onset encephalopathy or rapidly progressing dementia. Anti-N-methyl-D-aspartate receptor (NMDA-R) encephalitis is the most studied form and Hashimoto encephalitis is the most controversial form of autoimmune encephalopathies. Obtaining a combined serum and Cerebrospinal fluid (CSF) autoantibody testing will increase the diagnostic yield of autoimmune and paraneoplastic encephalitis. When diagnosing NMDA receptor antibodies CSF is always more sensitive than serum and in contrast, voltage-gated potassium channel (VGKC) complex antibodies are more readily detectable in serum than in CSF. Neural-specific antibody tests frequently result after several weeks and treatment should be administered without a significant delay to prevent brain damage. Autoimmune encephalitis is often treatment responsive when immunotherapy (glucocorticoids, intravenous immune globulin, plasma exchange) is used in various combinations. The absence of inflammatory markers and autoantibodies in the serum or CSF may not rule out the possibility of paraneoplastic encephalopathies.</AbstractText>
          <CopyrightInformation>Copyright © 2022, Reddy et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Reddy</LastName>
            <ForeName>Pramod</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine, University of Florida College of Medicine, Jacksonville, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Culpepper</LastName>
            <ForeName>Kaleb</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology, University of Florida College of Medicine, Jacksonville, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cureus</MedlineTA>
        <NlmUniqueID>101596737</NlmUniqueID>
        <ISSNLinking>2168-8184</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">acute disseminated encephalomyelitis</Keyword>
        <Keyword MajorTopicYN="N">autoimmune encephalitis</Keyword>
        <Keyword MajorTopicYN="N">bickerstaff brainstem encephalitis</Keyword>
        <Keyword MajorTopicYN="N">hashimoto encephalopathy</Keyword>
        <Keyword MajorTopicYN="N">nmda-r encephalitis</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic encephalitis</Keyword>
        <Keyword MajorTopicYN="N">primary cns vasculitis</Keyword>
      </KeywordList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>5</Hour>
          <Minute>11</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35291547</ArticleId>
        <ArticleId IdType="pmc">PMC8917954</ArticleId>
        <ArticleId IdType="doi">10.7759/cureus.22102</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Brain. 2000;123:1481–1494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10869059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhombencephalitis: a series of 97 patients. Moragas M, Martínez-Yélamos S, Majós C, Fernández-Viladrich P, Rubio F, Arbizu T. Medicine (Baltimore) 2011;90:256–261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21694648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Dalmau J, Graus F, Rosenblum MK, Posner JB. Medicine (Baltimore) 1992;71:59–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1312211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delirium in elderly people. Inouye SK, Westendorp RG, Saczynski JS. Lancet. 2014;383:911–922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4120864</ArticleId>
            <ArticleId IdType="pubmed">23992774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>High-dose parenteral thiamine in treatment of Wernicke's encephalopathy: case series and review of the literature. Nishimoto A, Usery J, Winton JC, Twilla J. In Vivo. 2017;31:121–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5354137</ArticleId>
            <ArticleId IdType="pubmed">28064230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Posterior reversible encephalopathy syndrome. Fischer M, Schmutzhard E. J Neurol. 2017;264:1608–1616.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5533845</ArticleId>
            <ArticleId IdType="pubmed">28054130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nonconvulsive status epilepticus and coma. Bauer G, Trinka E. Epilepsia. 2010;51:177–190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19744116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nonconvulsive status epilepticus in palliative care patients. Lorenzl S, Mayer S, Feddersen B, Jox R, Noachtar S, Borasio GD. J Pain Symptom Manage. 2010;40:460–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20594804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. McGuire LI, Peden AH, Orrú CD. Ann Neurol. 2012;72:278–285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3458796</ArticleId>
            <ArticleId IdType="pubmed">22926858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delayed MR imaging changes in acute disseminated encephalomyelitis. Honkaniemi J, Dastidar P, Kähärä V. https://onlinelibrary.wiley.com/doi/full/10.1002/ana.23589. AJNR Am J Neuroradiol. 2001;22:1117–1124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7974795</ArticleId>
            <ArticleId IdType="pubmed">11415907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickerstaff's brainstem encephalitis presenting to the ICU. Hunter G, Young GB, Ang LC. Neurocrit Care. 2012;17:102–106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22622843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Primary and secondary central nervous system vasculitis. Gowdie P, Twilt M, Benseler SM. J Child Neurol. 2012;27:1448–1459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23006496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diagnostic value and safety of brain biopsy in patients with cryptogenic neurological disease: a systematic review and meta-analysis of 831 cases. Bai HX, Zou Y, Lee AM, Lancaster E, Yang L. Neurosurgery. 2015;77:283–295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25856111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases. Lyons MK, Caselli RJ, Parisi JE. J Neurosurg. 2008;108:1024–1027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18447724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Dalmau J, Armangué T, Planagumà J. Lancet Neurol. 2019;18:1045–1057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31326280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Role of autoantibodies to N-methyl-d-aspartate (NMDA) receptor in relapsing herpes simplex encephalitis: a retrospective, one-center experience. Sutcu M, Akturk H, Somer A, et al.  J Child Neurol. 2016;31:345–350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26184485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimoto encephalopathy in the 21st century. Mattozzi S, Sabater L, Escudero D, et al.  Neurology. 2020;94:0–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31882532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Current knowledge on Hashimoto's encephalopathy: a literature review. Pinedo-Torres I, Paz-Ibarra JL. Medwave. 2018;18:0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30451215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long-term treatment of Hashimoto's encephalopathy. Marshall GA, Doyle JJ. J Neuropsychiatry Clin Neurosci. 2006;18:14–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16525066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>An overview of autoimmune and paraneoplastic encephalitides. Bradshaw MJ, Linnoila JJ. Semin Neurol. 2018;38:330–343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30011413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>A clinical approach to diagnosis of autoimmune encephalitis. Graus F, Titulaer MJ, Balu R, et al.  Lancet Neurol. 2016;15:391–404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5066574</ArticleId>
            <ArticleId IdType="pubmed">26906964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Application of plasma exchange in steroid-responsive encephalopathy. Jiang Y, Tian X, Gu Y, Li F, Wang X. Front Immunol. 2019;10:324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6400967</ArticleId>
            <ArticleId IdType="pubmed">30873174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Intravenous immune globulin in autoimmune and inflammatory diseases. Gelfand EW. N Engl J Med. 2012;367:2015–2025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23171098</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
